Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors
Author:
Publisher
Informa Healthcare
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/14728222.2010.515980
Reference140 articles.
1. Malignant glioma: genetics and biology of a grave matter
2. Drug Insight: gastrointestinal stromal tumors (GIST)—the solid tumor model for cancer-specific treatment
3. Review of Oncology and Hematology Drug Product Approvals at the US Food and Drug Administration Between July 2005 and December 2007
Cited by 139 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Revolutionizing Lung Cancer Treatment: Nanotechnology-Driven Advances in Targeted Drug Delivery and Novel Therapeutic Strategies;Journal of Drug Delivery Science and Technology;2024-09
2. MerTK Drives Proliferation and Metastatic Potential in Triple-Negative Breast Cancer;International Journal of Molecular Sciences;2024-05-08
3. In-situ SERS monitoring of membrane receptor PTK7 for assessing cancer cell migration at single-cell level on a microfluidic chip;Sensors and Actuators B: Chemical;2024-04
4. Virtual screening of natural product as TAM family of RTK inhibitor;Nanotechnology and In Silico Tools;2024
5. An Overview of Systemic Targeted Therapy in Renal Cell Carcinoma, with a Focus on Metastatic Renal Cell Carcinoma and Brain Metastases;Current Issues in Molecular Biology;2023-09-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3